Altamira Therapeutics Ltd.: xbrl:AdjustmentsForDecreaseIncreaseInPrepaidExpenses

Value{"amount": 161305, "currency": "USD"}
Period2025-01-01 – 2025-06-30
Statuscurrent
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-25-082071
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/87a78457-3437-4096-8af8-8b2cf0109d69

History